Director Stephen LaNeve resigns from Bone Biologics board

Bone Biologics Corp

Stephen LaNeve resigned as a director effective December 18, 2022.
Resignation was not due to any disagreement with the company's operations, policies, or practices.
Company expressed appreciation for Mr. LaNeve's years of service.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Stephen LaNeve

director

BBLG · Bone Biologics Corp

Effective: 2022-12-18
Filed: December 21, 2022, 6:59 PM ET

Effective December 18, 2022 Stephen LaNeve resigned as a director of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Stephen LaNeve resigned as director at Bone Biologics Corp.

Action: resigned
Role: director

Exact text from the filing

Effective December 18, 2022 Stephen LaNeve resigned as a director of the Company.

View on SEC.gov

Bone Biologics Corp filing history →

Source: SEC EDGAR

accession 0001493152-22-036161

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.